Zions Bancorporation’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $7.97M | Buy |
165,350
+10,990
| +7% | +$559K | 0.5% | 32 |
|
|
2024
Q3 | $8.9M | Sell |
154,360
-3,848
| -2% | -$208K | 0.65% | 19 |
|
|
2024
Q2 | $7.68M | Buy |
158,208
+39,708
| +34% | +$1.92M | 0.61% | 22 |
|
|
2024
Q1 | $5.76M | Buy |
118,500
+48,633
| +70% | +$2.37M | 0.42% | 42 |
|
|
2023
Q4 | $3.47M | Sell |
69,867
-23,924
| -26% | -$1.17M | 0.24% | 75 |
|
|
2023
Q3 | $5.03M | Buy |
93,791
+5,566
| +6% | +$297K | 0.44% | 39 |
|
|
2023
Q2 | $4.76M | Buy |
88,225
+17,805
| +25% | +$958K | 0.4% | 40 |
|
|
2023
Q1 | $3.83M | Buy |
70,420
+69,157
| +5,476% | +$3.36M | 0.33% | 53 |
|
|
2022
Q4 | $61.2K | Sell |
1,263
-7,249
| -85% | -$318K | ﹤0.01% | 419 |
|
|
2022
Q3 | $324K | Sell |
8,512
-1,195
| -12% | -$53.3K | 0.03% | 262 |
|
|
2022
Q2 | $486K | Buy |
9,707
+1,157
| +14% | +$61.4K | 0.05% | 240 |
|
|
2022
Q1 | $439K | Buy |
8,550
+2,702
| +46% | +$140K | 0.04% | 257 |
|
|
2021
Q4 | $293K | Buy |
5,848
+3,271
| +127% | +$162K | 0.03% | 276 |
|
|
2021
Q3 | $124K | Buy |
2,577
+741
| +40% | +$37.7K | 0.01% | 342 |
|
|
2021
Q2 | $97K | Buy |
1,836
+994
| +118% | +$51.9K | 0.01% | 354 |
|
|
2021
Q1 | $42K | Sell |
842
-157
| -16% | -$7.54K | ﹤0.01% | 446 |
|
|
2020
Q4 | $49K | Sell |
999
-317
| -24% | -$15.6K | 0.01% | 398 |
|
|
2020
Q3 | $66K | Sell |
1,316
-26
| -2% | -$1.34K | 0.01% | 331 |
|
|
2020
Q2 | $69K | Buy |
1,342
+10
| +0.8% | +$486 | 0.01% | 306 |
|
|
2020
Q1 | $58K | Sell |
1,332
-554
| -29% | -$26.5K | 0.01% | 306 |
|
|
2019
Q4 | $95K | Sell |
1,886
-143
| -7% | -$6.7K | 0.01% | 321 |
|
|
2019
Q3 | $94K | Buy |
2,029
+202
| +11% | +$8.71K | 0.01% | 338 |
|
|
2019
Q2 | $79K | Buy |
1,827
+404
| +28% | +$17.2K | 0.01% | 331 |
|
|
2019
Q1 | $63K | Sell |
1,423
-72
| -5% | -$3.08K | 0.01% | 370 |
|
|
2018
Q4 | $65K | Sell |
1,495
-171
| -10% | -$7.54K | 0.05% | 145 |
|
|
2018
Q3 | $74K | Sell |
1,666
-17,674
| -91% | -$755K | 0.02% | 271 |
|
|
2018
Q2 | $774K | Buy |
19,340
+1,544
| +9% | +$60.8K | 0.53% | 37 |
|
|
2018
Q1 | $713K | Sell |
17,796
-179
| -1% | -$7.45K | 0.16% | 56 |
|
|
2017
Q4 | $773K | Sell |
17,975
-6,465
| -26% | -$298K | 0.13% | 67 |
|
|
2017
Q3 | $1.22M | Buy |
24,440
+23,560
| +2,677% | +$1.14M | 0.18% | 79 |
|
|
2017
Q2 | $42K | Sell |
880
-201
| -19% | -$9.61K | 0.01% | 225 |
|
|
2017
Q1 | $50K | Sell |
1,081
-136
| -11% | -$5.77K | 0.01% | 198 |
|
|
2016
Q4 | $49K | Buy |
1,217
+53
| +5% | +$2.09K | 0.01% | 241 |
|
|
2016
Q3 | $44K | Buy |
1,164
+150
| +15% | +$6.02K | 0.01% | 250 |
|
|
2016
Q2 | $42K | Sell |
1,014
-123
| -11% | -$5.04K | 0.01% | 234 |
|
|
2016
Q1 | $48K | Buy |
1,137
+150
| +15% | +$6.03K | 0.01% | 246 |
|
|
2015
Q4 | $39K | Sell |
987
-309
| -24% | -$14.2K | 0.01% | 246 |
|
|
2015
Q3 | $61K | Buy |
1,296
+1,196
| +1,196% | +$60.9K | 0.01% | 189 |
|
|
2015
Q2 | $5K | Sell |
100
-1,113
| -92% | -$56.4K | ﹤0.01% | 241 |
|
|
2015
Q1 | $60K | Buy |
+1,213
| New | +$58K | 0.01% | 204 |
|
Other funds holding SNY
Zions Bancorporation's SNY Position: Q4 2024 in Review
Zions Bancorporation increased its Sanofi (SNY) stake by 7.1% in Q4 2024, buying an estimated $559K and bringing the position to 165,350 shares worth $7.97M. The position accounts for 0.5% of the portfolio, ranked #32.
Zions Bancorporation first reported a position in SNY in Q1 2015 and has held it in 40 quarters since. The position peaked at $8.9M in Q3 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q4 2024.
- Zions Bancorporation held 165,350 shares of Sanofi worth $7.97M as of Q4 2024.
- Zions Bancorporation bought 10,990 Sanofi shares in Q4 2024, an estimated $559K.
- Sanofi made up 0.5% of Zions Bancorporation's portfolio in Q4 2024, its #32 holding.
- Zions Bancorporation first reported a position in Sanofi in Q1 2015 and has held it in 40 quarters since.
- Zions Bancorporation's Sanofi position peaked at $8.9M in Q3 2024.
- 731 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.